|
Sygnature Discovery announces multi target drug discovery deal with Sitryx Therapeutics
Sygnature Discovery has announced a multi target, integrated drug discovery collaboration with Sitryx Therapeutics, a biopharmaceutical company focused...
|
|
 Proprietary Nasal Delivery Formulation of Diazepam Developed by Particle Sciences Reaches NDA
Proprietary nasal delivery formulation has been submitted as a New Drug Application to the U.S. FDA by San Diego based Neurelis Inc.
|
|